Mark D. Prairie

536 total citations
21 papers, 438 citations indexed

About

Mark D. Prairie is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Mark D. Prairie has authored 21 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Toxicology. Recurrent topics in Mark D. Prairie's work include Cancer therapeutics and mechanisms (10 papers), DNA and Nucleic Acid Chemistry (8 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Mark D. Prairie is often cited by papers focused on Cancer therapeutics and mechanisms (10 papers), DNA and Nucleic Acid Chemistry (8 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Mark D. Prairie collaborates with scholars based in United States and Norway. Mark D. Prairie's co-authors include William C. Krueger, Robert C. Kelly, J. Patrick McGovren, Tanya L. Wallace, Martha A. Warpehoski, Gary L. Petzold, Nancy A. Wicnienski, Wendell Wierenga, T F Dekoning and Ilse Gebhard and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Mark D. Prairie

21 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark D. Prairie United States	9	358	162	71	70	56	21	438
Alexander P. Ducruet United States	9	453 1.3×	146 0.9×	96 1.4×	99 1.4×	47 0.8×	10	545
J.A. Hartley United Kingdom	12	311 0.9×	155 1.0×	68 1.0×	76 1.1×	19 0.3×	22	424
Gregory A. Rener United States	11	285 0.8×	336 2.1×	93 1.3×	28 0.4×	53 0.9×	20	596
Kazuhiro Fukasawa Japan	11	345 1.0×	183 1.1×	203 2.9×	63 0.9×	36 0.6×	19	538
C. Caroline O’Hare United Kingdom	14	377 1.1×	185 1.1×	101 1.4×	54 0.8×	22 0.4×	24	525
Judith Markovits France	15	642 1.8×	198 1.2×	171 2.4×	139 2.0×	34 0.6×	24	764
Caleb Foster United States	12	333 0.9×	131 0.8×	64 0.9×	109 1.6×	50 0.9×	13	528
Damian O. Arnaiz United States	13	283 0.8×	345 2.1×	42 0.6×	27 0.4×	27 0.5×	18	617
Martin L. Stockley United Kingdom	8	213 0.6×	173 1.1×	113 1.6×	36 0.5×	60 1.1×	8	384
Xiao‐Hui Gu China	9	223 0.6×	311 1.9×	128 1.8×	39 0.6×	33 0.6×	13	606

Countries citing papers authored by Mark D. Prairie

Since Specialization

Citations

This map shows the geographic impact of Mark D. Prairie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Prairie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Prairie more than expected).

Fields of papers citing papers by Mark D. Prairie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Prairie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Prairie. The network helps show where Mark D. Prairie may publish in the future.

Co-authorship network of co-authors of Mark D. Prairie

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Prairie. A scholar is included among the top collaborators of Mark D. Prairie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Prairie. Mark D. Prairie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuo, Ming‐Shang, et al.. (1999). Isolation and identification of a major metabolite of PNU‐107859, an MMP inhibitor from the biliary fluid of rats. Journal of Pharmaceutical Sciences. 88(7). 705–708. 6 indexed citations

Fairbanks, Michael B., et al.. (1995). Purification and structural characterization of the CD11b/CD18 integrin α subunit I domain reveals a folded conformation in solution. FEBS Letters. 369(2-3). 197–201. 7 indexed citations

Friedman, Alan R., et al.. (1992). Growth hormone-releasing factor analogs with hydrophobic residues at position 19. Effects on growth hormone releasing activity in vitro and in vivo, stability in blood plasma in vitro, and secondary structure. Journal of Medicinal Chemistry. 35(21). 3928–3933. 6 indexed citations

Yem, Anthony W., David M. Guido, W. Rodney Mathews, et al.. (1992). Chemical modification of Interleukin-1β: Biochemical characterization of a carbodiimide-catalyzed intramolecular cross-linked protein. Journal of Protein Chemistry. 11(6). 709–722. 5 indexed citations

Krueger, William C. & Mark D. Prairie. (1992). Calf thymus DNA binding/bonding properties of CC-1065 and analogs as related to their biological activities and toxicities. Chemico-Biological Interactions. 82(1). 31–46. 7 indexed citations

Dekoning, T F, Robert C. Kelly, William C. Krueger, et al.. (1992). Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue.. PubMed. 52(18). 4904–13. 81 indexed citations

Krueger, William C., et al.. (1991). DNA sequence recognition by the antitumor antibiotic CC-1065 and analogs of CC-1065. Chemico-Biological Interactions. 79(3). 265–286. 6 indexed citations

Krueger, William C. & Mark D. Prairie. (1991). The origin of the DNA induced circular dichroism of CC-1065 and analogs. Chemico-Biological Interactions. 79(2). 137–149. 8 indexed citations

Epps, D E Van, John Cheney, Heinrich J. Schostarez, et al.. (1990). Thermodynamics of the interaction of inhibitors with the binding site of recombinant human renin. Journal of Medicinal Chemistry. 33(8). 2080–2086. 21 indexed citations

10.

Prairie, Mark D., et al.. (1989). Interaction of CC-1065 and its analogues with mouse DNA and chromatin.. PubMed. 49(8). 1983–8. 4 indexed citations

11.

Thériault, Nicole Y., William C. Krueger, & Mark D. Prairie. (1988). Studies on the base pair binding specificity of CC-1065 to oligomer duplexes. Chemico-Biological Interactions. 65(2). 187–201. 7 indexed citations

12.

Swenson, David H., et al.. (1988). Evaluation of DNA binding characteristics of some CC-1065 analogs. Chemico-Biological Interactions. 67(3-4). 199–213. 7 indexed citations

13.

Warpehoski, Martha A., Ilse Gebhard, Robert C. Kelly, et al.. (1988). Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC-1065. Journal of Medicinal Chemistry. 31(3). 590–603. 117 indexed citations

14.

Martin, David G., Robert C. Kelly, William Watt, et al.. (1988). Absolute configuration of CC-1065 by x-ray crystallography on a derivatized chiral fragment (CPI) from the natural antibiotic. The Journal of Organic Chemistry. 53(19). 4610–4613. 5 indexed citations

15.

Wallace, Tanya L., T F Dekoning, Martha A. Warpehoski, et al.. (1987). Structure and activity relationship of several novel CC-1065 analogs. Investigational New Drugs. 5(4). 329–337. 27 indexed citations

16.

Krueger, William C. & Mark D. Prairie. (1987). A circular dichroism study of the binding of CC-1065 to B and Z form poly(dl-5BrdC)·poly(dl-5BrdC). Chemico-Biological Interactions. 62(3). 281–295. 11 indexed citations

17.

Thériault, Nicole Y., William C. Krueger, & Mark D. Prairie. (1987). DNA Base Pair Binding Specificity of CC-1065. Nucleosides and Nucleotides. 6(1-2). 327–330. 1 indexed citations

18.

Krueger, William C., et al.. (1985). Binding of CC‐1065 to poly‐ and oligonucleotides. Biopolymers. 24(8). 1549–1572. 30 indexed citations

19.

Krueger, William C. & Mark D. Prairie. (1985). A low‐salt form of poly(dG‐5M‐dC) · poly(dG‐5M‐dC). Biopolymers. 24(5). 905–910. 18 indexed citations

20.

Li, Li H., et al.. (1984). Mechanism of action of didemnin B, a depsipeptide from the sea. Cancer Letters. 23(3). 279–288. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact